# What can these findings tell you about recovery? > Recovery & Tissue Repair research peptides: which claims hold up? — BPC-157, TB-500, KPV and GLOW: what the tests found and what you still cannot tell about Recovery & Tissue Repair research peptides. **QUESTIONS / CLAIMS MEET THE STUDIES** These peptides are under study for possible repair effects. Here you can separate tested findings from claims lacking human proof. ## What improved with BPC-157 in animal tests? In animals and cells, BPC-157 encouraged blood-vessel growth and cell movement [4]. Rats showed stomach-ulcer and tendon repair effects [5][18]. Human studies remain far fewer [1][2]. These findings give researchers work to pursue, rather than a healing time for you. Your injury hasn't been shown to heal at the animals' pace. ## Does BPC-157 act as growth hormone? Growth hormone helps the body direct growth and repair; BPC-157 isn't that hormone. Researchers make the peptide from fifteen amino acids, which are also used to build proteins. The recipe matches a section of protein found in stomach fluid. Researchers propose that tendon cells respond more strongly when growth hormone is present. The cited work better describes new blood-vessel growth [4]. A proposed effect on a hormone's action doesn't make the substances the same. ## When would BPC-157 bring relief, if it helps? An immediate healing effect in people hasn't been shown for this peptide. In rats and dogs, removal and breakdown happened quickly [3]. Rapid removal doesn't show rapid relief for you. **People using the peptide for research describe their own timing of changes. Comparison trials haven't checked those accounts.** These papers don't give a dependable waiting time. Human healing studies remain too limited [2]. ## Did the BPC-157 safety test find liver changes? The safety test with two adults found no measured liver blood-test change [1]. That is reassuring for those people during a very short test. Rare or lasting liver harm could still be missed. The review concluded that thorough trials in people were still missing [2]. You cannot judge your own liver risk from a two-person test. ## How is TB-500 different from the larger protein? TB-500 has seven linked amino acids; these parts also form proteins. Whole thymosin beta-4 has forty-three, making the whole protein much larger. Manufacture adds an acetyl attachment, containing carbon, hydrogen and oxygen, to the small peptide's end. Studies mainly concern whole thymosin beta-4 holding a protein involved in how cells move [8][10]. You can't assign the larger protein's effects to the small piece without testing. ## Do the injury studies test TB-500 itself? 2026: animal repair looked encouraging in a review of unapproved peptides such as TB-500 [6]. Thorough human safety research remained scarce. Researchers discuss the small peptide for tissue and exercise recovery. Yet wound and stroke studies mainly concern the whole protein [7][8]. Those results don't show that the small piece repairs your injury. ## Has TB-500 healed muscle tears in human trials? The papers contain no controlled human trial proving that benefit for the small peptide. **People describe their own recovery while trying the substances for research. No trial has compared those claims against results from another treatment.** The human safety trial examined whole thymosin beta-4 [9]. The review judged human evidence on unapproved injury peptides to be scarce [6]. You still lack trial proof about healing muscle tears with the small peptide. ## Which hormone supplied the recipe for KPV? KPV joins three amino acids, each a small part used in proteins. Their order matches the end of a hormone involved in coloring skin. A hormone carries messages in the body. The review described less inflammation without changing skin color as the full hormone does [15]. Experiments used cells, mice with gut inflammation and protected preparations [11][12][13][14]. Your gut's possible benefit remains unanswered by these tests. ## What got better in mice given protected KPV? KPV entered gut cells using a protein bringing small peptides through the cell's surface [13]. Preparations using protective particles or gel reduced gut inflammation and lining damage in mice [11][12]. The protection was part of what researchers tested. Loose peptide hasn't been shown to relieve your symptoms in a human trial. ## Does the name GLOW describe a fixed recipe? GLOW usually combines GHK-Cu, BPC-157 and TB-500. The amounts can differ; no trial here compares all three together with another treatment. Studies concern the ingredients separately [2][6][16][17]. You cannot infer the mixture's effects from separate ingredient claims. ## Which ingredient findings are used to explain GLOW? GHK-Cu reviews discuss tissue supporting skin [16][17]. BPC-157 work concerns new vessels carrying blood and repair of tendons [4][18]. Whole thymosin beta-4 studies examine wounds and moving cells [8][19]. These give reasons to investigate a mixture, without a controlled test proving the combined effect. The claimed combined help remains untested for you. ## How can you tell whether a bottle matches study material? Researchers must identify the substance, including its length and any added attachments. Tests need to distinguish a whole protein, a small piece and a mixture. Several tests must agree with a known substance for comparison. Unwanted material also needs checking. A paper cannot certify every other bottle bearing the same name for you. --- An independent repair-peptide evidence desk that checks the molecule before the claim—not a store, a purity verdict or medical advice.